Genetic and Nutritional Causes of Heart Birth Defects

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1610 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-07-31

Study Completion Date

2006-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Each year in the United States, thousands of babies are born with heart defects. Women who take folic acid during pregnancy have a lower risk of giving birth to infants with heart defects, but the reason for this remains unknown. This study will examine the relationship between genes, nutrition, and the occurrence of heart defects in infants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fetal Growth and Pregnancy Complications Among Women With Heart Disease

NCT03657823

Congenital Heart Disease Pregnancy Complications Arrhythmias, Cardiac +1 more

UNKNOWN

The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study

NCT06517628

Pregnancy Complications, Cardiovascular

RECRUITING

Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes

NCT04769167

Congenital Heart Disease Viremia Virus Diseases +12 more

COMPLETED NA

Cardiometabolic Health in First Time Pregnancy

NCT05856318

Cardiometabolic Health Pregnancy Related Diabetes +2 more

RECRUITING

Calcium Intake, Metabolism, and Gestational Blood Pressure

NCT00005206

Cardiovascular Diseases Heart Diseases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Congenital heart defects are the most common type of birth defect; each year, more than 30,000 babies in the United States are born with this kind of abnormality. Conotruncal heart defects, considered to be a very serious type of defect, involve a structural abnormality in the chambers of the heart or blood vessels that lead to and from the heart. Infants born with conotruncal defects must undergo complex open heart surgery, and there is a high fatality rate. Folic acid supplementation during pregnancy has been shown to reduce the risk of conotruncal defects. However, some women who take folic acid during pregnancy still give birth to infants with conotruncal defects. Specific genes may influence the way individuals metabolize folic acid, and variations in these genes may make some infants more prone to developing heart defects. This study will examine the relationship between genes, maternal nutritional intake, and conotruncal heart defects. The results from this study may help to determine genetic and nutritional causes of congenital heart defects.

This study will use previously collected data on 550 infants born with conotruncal defects and 1060 infants born without heart defects. There will be no study visits specifically for this study. Infant DNA will be analyzed for genes that may play a role in folate metabolic pathways. Blood previously collected from the mothers during pregnancy will be analyzed for differences in nutrient intake. Specifically, levels of folic acid, choline, vitamin B12, and methionine will be examined.